AR068467A1 - Compuestos de nicotinamida sustituida y sus usos en medicamentos - Google Patents
Compuestos de nicotinamida sustituida y sus usos en medicamentosInfo
- Publication number
- AR068467A1 AR068467A1 ARP080104040A ARP080104040A AR068467A1 AR 068467 A1 AR068467 A1 AR 068467A1 AR P080104040 A ARP080104040 A AR P080104040A AR P080104040 A ARP080104040 A AR P080104040A AR 068467 A1 AR068467 A1 AR 068467A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- denotes
- substituted
- mono
- unsubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuestos de nicotinamida sustituida, a medicamentos que comprenden estos compuestos y al uso de estos compuestos en la preparacion de medicamentos para el tratamiento de enfermedades parcialmente medidas por canales KCNQ2/3KT. Reivindicacion 1: Un compuesto de nicotinamida sustituida de la formula general 1 caracterizado porque n = 0, 1 o 2; p = 0 o 1; q = 0 o 1; R1 denota arilo o heteroarilo, no sustituido o mono o poli-sustituido; alquilo C1-6, ciclo alquilo C3-10 o heterocíclico, no sustituido o mono o polisustituido. R2 denota H; C1-6 alquilo, no sustituido o mono o poli-sustituido; R3 denota arilo o heteroarilo, no sustituido o mono o poli-sustituido; alquilo C1-6 o cicloalquilo C3-10, en cada caso no sustituido o mono o polisustituido; R4, R5, R6 y R7 independientemente uno del otro representan H alquilo C1-6, no sustituido o mono o poli-sustituido; R8, R9, R10 independientemente uno del otro denota H, F, CI, Br, O-C1-6 alquilo, CF3, OCF3, SCF3, alquilo C1-6; Con la salvedad que cuando R3 denota 3-trifluorometilfenil o 4-trifluoro- metil-2-piridil, R2, R4 y R5 denotan H y n denota O, luego R1 no denota 2- piridil o 2- tienil Y cuando R3 denota fenil o metil, R2, R4 y R5 denota H y n denota O, luego R1 no denota 2-tienil, en la forma de racimo; de enantiomeros, diaesteroisomeros, mezcla de enantiomeros o diasteroisomeros o de un enantiomero o diasteroisomero individual, de las bases y/o ácidos fisiologicamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007044277A DE102007044277A1 (de) | 2007-09-17 | 2007-09-17 | Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR068467A1 true AR068467A1 (es) | 2009-11-18 |
Family
ID=40347805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080104040A AR068467A1 (es) | 2007-09-17 | 2008-09-17 | Compuestos de nicotinamida sustituida y sus usos en medicamentos |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8084470B2 (es) |
| EP (1) | EP2188258B1 (es) |
| JP (1) | JP5539205B2 (es) |
| KR (1) | KR20100068453A (es) |
| CN (1) | CN101801932A (es) |
| AR (1) | AR068467A1 (es) |
| BR (1) | BRPI0817044A2 (es) |
| CA (1) | CA2699689C (es) |
| CO (1) | CO6260092A2 (es) |
| CY (1) | CY1113551T1 (es) |
| DE (1) | DE102007044277A1 (es) |
| DK (1) | DK2188258T3 (es) |
| ES (1) | ES2400407T3 (es) |
| HK (1) | HK1144422A1 (es) |
| HR (1) | HRP20130166T1 (es) |
| IL (1) | IL204496A (es) |
| MX (1) | MX2010002506A (es) |
| NZ (1) | NZ583684A (es) |
| PE (1) | PE20090652A1 (es) |
| PL (1) | PL2188258T3 (es) |
| PT (1) | PT2188258E (es) |
| RU (1) | RU2489425C2 (es) |
| SI (1) | SI2188258T1 (es) |
| WO (1) | WO2009036938A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI475020B (zh) * | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
| WO2012025236A1 (en) * | 2010-08-27 | 2012-03-01 | Grünenthal GmbH | Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators |
| AU2011317855B2 (en) * | 2010-10-20 | 2015-04-30 | Grunenthal Gmbh | Substituted 6-amino-nicotinamides as KCNQ2/3 modulators |
| FR2968661B1 (fr) * | 2010-12-14 | 2016-01-01 | Oreal | Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones |
| EP2906217A1 (en) * | 2012-10-11 | 2015-08-19 | Grünenthal GmbH | Treatment and/or prophylaxis of tspo mediated diseases and/or disorders |
| MX2015006689A (es) | 2012-11-28 | 2015-08-20 | Grünenthal GmbH | Carboxamidas especificas como moduladores de kcnq2/3. |
| US9248122B2 (en) | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
| US11046683B2 (en) | 2016-12-15 | 2021-06-29 | Ono Pharmaceutical Co., Ltd. | Activator of TREK (TWIK RElated K+ channels) channels |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6022884A (en) * | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
| GB9919588D0 (en) * | 1999-08-18 | 1999-10-20 | Hoechst Schering Agrevo Gmbh | Fungicidal compounds |
| WO2002072088A2 (en) | 2001-02-20 | 2002-09-19 | Bristol-Myers Squibb Company | Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| GB0319793D0 (en) * | 2003-08-22 | 2003-09-24 | Lilly Co Eli | Pyridinylmorpholine derivatives |
-
2007
- 2007-09-17 DE DE102007044277A patent/DE102007044277A1/de not_active Withdrawn
-
2008
- 2008-09-15 JP JP2010524410A patent/JP5539205B2/ja not_active Expired - Fee Related
- 2008-09-15 ES ES08802179T patent/ES2400407T3/es active Active
- 2008-09-15 PT PT88021795T patent/PT2188258E/pt unknown
- 2008-09-15 DK DK08802179.5T patent/DK2188258T3/da active
- 2008-09-15 RU RU2010115184/04A patent/RU2489425C2/ru not_active IP Right Cessation
- 2008-09-15 EP EP08802179A patent/EP2188258B1/de active Active
- 2008-09-15 KR KR1020107008408A patent/KR20100068453A/ko not_active Application Discontinuation
- 2008-09-15 WO PCT/EP2008/007633 patent/WO2009036938A1/de active Application Filing
- 2008-09-15 SI SI200830849T patent/SI2188258T1/sl unknown
- 2008-09-15 NZ NZ583684A patent/NZ583684A/en not_active IP Right Cessation
- 2008-09-15 CA CA2699689A patent/CA2699689C/en not_active Expired - Fee Related
- 2008-09-15 BR BRPI0817044 patent/BRPI0817044A2/pt not_active IP Right Cessation
- 2008-09-15 PL PL08802179T patent/PL2188258T3/pl unknown
- 2008-09-15 MX MX2010002506A patent/MX2010002506A/es active IP Right Grant
- 2008-09-15 CN CN200880107279A patent/CN101801932A/zh active Pending
- 2008-09-17 PE PE2008001619A patent/PE20090652A1/es not_active Application Discontinuation
- 2008-09-17 AR ARP080104040A patent/AR068467A1/es not_active Application Discontinuation
- 2008-09-17 US US12/212,369 patent/US8084470B2/en not_active Expired - Fee Related
-
2010
- 2010-03-12 CO CO10029446A patent/CO6260092A2/es not_active Application Discontinuation
- 2010-03-15 IL IL204496A patent/IL204496A/en not_active IP Right Cessation
- 2010-11-18 HK HK10110728.6A patent/HK1144422A1/xx not_active IP Right Cessation
-
2013
- 2013-01-15 CY CY20131100043T patent/CY1113551T1/el unknown
- 2013-02-27 HR HRP20130166AT patent/HRP20130166T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20090652A1 (es) | 2009-05-28 |
| CN101801932A (zh) | 2010-08-11 |
| DK2188258T3 (da) | 2013-01-14 |
| JP2010539124A (ja) | 2010-12-16 |
| KR20100068453A (ko) | 2010-06-23 |
| BRPI0817044A2 (pt) | 2015-03-24 |
| EP2188258A1 (de) | 2010-05-26 |
| PT2188258E (pt) | 2013-01-23 |
| NZ583684A (en) | 2011-04-29 |
| RU2489425C2 (ru) | 2013-08-10 |
| US8084470B2 (en) | 2011-12-27 |
| RU2010115184A (ru) | 2011-10-27 |
| CA2699689C (en) | 2015-03-24 |
| HK1144422A1 (en) | 2011-02-18 |
| DE102007044277A1 (de) | 2009-03-19 |
| CO6260092A2 (es) | 2011-03-22 |
| WO2009036938A1 (de) | 2009-03-26 |
| ES2400407T3 (es) | 2013-04-09 |
| IL204496A (en) | 2013-02-28 |
| AU2008300945A1 (en) | 2009-03-26 |
| CA2699689A1 (en) | 2009-03-26 |
| CY1113551T1 (el) | 2016-06-22 |
| MX2010002506A (es) | 2010-03-26 |
| PL2188258T3 (pl) | 2013-04-30 |
| US20090076086A1 (en) | 2009-03-19 |
| SI2188258T1 (sl) | 2013-01-31 |
| JP5539205B2 (ja) | 2014-07-02 |
| HRP20130166T1 (hr) | 2013-03-31 |
| EP2188258B1 (de) | 2012-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR068467A1 (es) | Compuestos de nicotinamida sustituida y sus usos en medicamentos | |
| CY1116885T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου | |
| PE20171341A1 (es) | Compuestos de pirazina para el tratamiento de enfermedades infecciosas | |
| MX2010001080A (es) | Pirrolidin-aril-eteres como antagonistas de receptor de nk3. | |
| AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| HRP20050870A2 (en) | Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter | |
| NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
| ECSP045229A (es) | Piridinonas sustituidas como moduladores de la p38 map quinasa | |
| MX348920B (es) | Derivados de 2-(fenil o pirid-3-il)aminopirimidina como moduladores de proteina cinasa 2 de repeticion rica en leucina (lrrk2) para el tratamiento de la enfermedad de parkinson. | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| AR051754A1 (es) | Metodos para preparar compuestos de indazol | |
| AR048834A1 (es) | Compuestos derivados de piperidina o tropano; metodos para su preparacion; composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por quimioquinas (ccr5) | |
| UY28903A1 (es) | Nuevos derivados de piridazinona | |
| CY1114112T1 (el) | Νεα αρυλαμιδια υποκατεστημενα με πυραζολιο | |
| AR054508A1 (es) | Compuesto de bencilpiperazina, su uso para preparar un medicamento, procedimientos para la preparacion de dicho compuesto y de compuestos intermediarios, dichos compuestos intermediarios, composicion farmaceutica que lo comprende y procedimiento para prepararla | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| EA200601845A1 (ru) | НОВЫЕ β-АГОНИСТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
| AR055666A1 (es) | Inhibidores inntr | |
| ATE488510T1 (de) | Heterocyclische derivate, deren herstellung und therapeutische verwendung | |
| AR060956A1 (es) | Derivados de 1-[4-[benzoil(metil)amino]-3-(fenil)butil]azetidina para el trata-miento de desordenes gastrointestinales | |
| EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
| WO2007048841A3 (de) | Neue indol-haltige beta-agonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| ES2526420T3 (es) | Derivados de pirrolidina como antagonistas de NK3 | |
| AR083718A1 (es) | Fenil cicloalquil pirrolidina (piperidina) espirolactamas y amidas sustituidas, preparacion y uso terapeutico de las mismas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |